ISA247

Known as: trans-ISA247 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Voclosporin (VCS, ISA247) is a novel calcineurin inhibitor being developed for organ transplantation. PROMISE was a 6-month… (More)
Is this relevant?
2009
2009
Several drugs currently under development may have uses in transplantation, whether they are developed directly in this domain or… (More)
Is this relevant?
2008
2008
BACKGROUND The use of systemic calcineurin inhibitors for the treatment of patients with psoriasis is limited by toxicity… (More)
Is this relevant?
2008
2008
BACKGROUND Psoriasis is a chronic skin condition that can negatively affect a patient's quality of life (QoL), often hindering… (More)
Is this relevant?
Review
2008
Review
2008
The first decade of the new millennium has been disappointing for transplant therapeutics: no new immunosuppression agents have… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
Is this relevant?
2006
2006
BACKGROUND Use of current oral calcineurin inhibitors for the treatment of psoriasis is limited by toxicity. OBJECTIVE Evaluate… (More)
Is this relevant?
2004
2004
ISA247 is a novel cyclosporine analog. In this study we compare, in vitro, the effects of ISA247 on immune function with those of… (More)
Is this relevant?